{"news_desk": "Business", "print_page": "6", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By ALEXANDRA STEVENSON and MATTHEW GOLDSTEIN", "person": [{"rank": 1, "role": "reported", "firstname": "Alexandra", "organization": "", "lastname": "STEVENSON"}, {"rank": 2, "role": "reported", "firstname": "Matthew", "organization": "", "lastname": "GOLDSTEIN"}]}, "abstract": "Pershing Square Capital Management founder William A Ackman testifies at Senate hearing on Valeant Pharmaceuticals' drug pricing policies; his hedge fund, along with others, have lost billions of dollars on Valeant, which has seen its share price plummet 85 percent since 2015.", "type_of_material": "News", "word_count": "1333", "lead_paragraph": "The crowding phenomenon comes amid a backdrop of turbulence for the hedge fund industry, where some of the biggest names have reported double-digit losses.", "pub_date": "2016-04-28T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "As Valeant Tumbles, So Does Bill Ackman\u2019s Hedge Fund Herd", "print_headline": "As Valeant Tumbles, So Does Billionaire\u2019s Hedge Fund Herd"}, "snippet": "The crowding phenomenon comes amid a backdrop of turbulence for the hedge fund industry, where some of the biggest names have reported double-digit losses.", "multimedia": [{"height": 126, "url": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbWide.jpg", "legacy": {"widewidth": "190", "wideheight": "126", "wide": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbWide.jpg"}, "type": "image", "width": 190, "subtype": "wide"}, {"height": 480, "url": "images/2016/04/28/business/28DB-HERD/28DEB-HERD-articleLarge.jpg", "legacy": {"xlargewidth": "600", "xlargeheight": "480", "xlarge": "images/2016/04/28/business/28DB-HERD/28DEB-HERD-articleLarge.jpg"}, "type": "image", "width": 600, "subtype": "xlarge"}, {"height": 75, "url": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbStandard.jpg", "legacy": {"thumbnailwidth": "75", "thumbnail": "images/2016/04/28/business/28DB-HERD/28DB-HERD-thumbStandard.jpg", "thumbnailheight": "75"}, "type": "image", "width": 75, "subtype": "thumbnail"}], "web_url": "http://www.nytimes.com/2016/04/28/business/dealbook/as-valeant-tumbles-so-does-billackmans-hedge-fund-herd.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Hedge Funds", "name": "subject"}, {"rank": "2", "is_major": "Y", "value": "Ackman, William A", "name": "persons"}, {"rank": "3", "is_major": "Y", "value": "Valeant Pharmaceuticals International Inc", "name": "organizations"}, {"rank": "4", "is_major": "Y", "value": "Pershing Square Capital Management", "name": "organizations"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Bankruptcies", "name": "subject"}], "blog": [], "_id": "57215bd738f0d83acb9a61f3", "source": "The New York Times"}